Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Aeterna Zentaris’ endometrial cancer drug fails in Phase III

pharmatimesMay 04, 2017

Tag: cancer , Drug

PharmaSources Customer Service